-
1
PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
2
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Published 2025-02-01Subjects: “…hepatocellular carcinoma (HCC)…”
Get full text
Article -
3
Identification of MORF4L1 as an endogenous substrate of CRBN and its potential role as a therapeutic target in cancer
Published 2025-01-01Subjects: Get full text
Article -
4
-
5
MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells
Published 2025-01-01Subjects: Get full text
Article